https://www.cnn.com/2023/11/08/health/zepbound-mounjaro-fda-approval-obesity/index.html
The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
Create an account or login to join the discussion